Welcome to our dedicated page for Piper Sandler Co`S news (Ticker: PIPR), a resource for investors and traders seeking the latest updates and insights on Piper Sandler Co`S stock.
Piper Sandler Companies reports news on its investment banking and institutional securities business, including advisory services, equity and debt capital markets, public finance, institutional brokerage, research, fixed income, and alternative asset management activities. Coverage commonly includes financial results, dividends, capital actions, and updates to teams serving corporate, private equity, public entity, nonprofit, and institutional investor clients.
Company announcements also cover platform expansion in areas such as distressed debt, special assets, healthcare investment banking, life sciences outsourcing, B2B med tech, and fixed income. Governance-related news includes board appointments and other corporate updates tied to the firm’s public-company structure.
Piper Sandler (NYSE:PIPR) is launching a distressed debt and special asset group within its fixed income platform, led by new managing directors John Mori (Greenwich) and Eric Friel (New York).
The group will source and trade specialized credit products and work closely with investment banking, capital markets and restructuring teams.
Mori and Friel join from Oppenheimer, bringing extensive distressed and high-yield experience.
Piper Sandler Companies (NYSE: PIPR) announced first-quarter 2026 results and scheduled an earnings conference call on May 1, 2026 at 7:30 a.m. CT. Investors can access the call by phone or via a live webcast; an audio playback will be available on the company website approximately three hours after the event.
Dial-in numbers and passcode are provided for U.S. and international participants, and the full earnings release is available at pipersandler.com/earnings.
Piper Sandler (NYSE: PIPR) announced the hiring of Patrick McCormack, M.D. as managing director in its healthcare investment banking group, based in San Francisco. McCormack will advise biopharma companies on mergers, acquisitions, and capital-raising transactions and joins from Wells Fargo Securities.
McCormack brings medical and MBA credentials and prior senior roles at Goldman Sachs, SVB Leerink, and SunTrust Robinson Humphrey.
Piper Sandler (NYSE: PIPR) will release first quarter 2026 financial results before market open on Friday, May 1, 2026. A conference call with CEO Chad Abraham, President Deb Schoneman, and CFO Kate Clune will follow at 8:30 a.m. ET to review results and take questions.
Investors can join via dial-in (800 330-6710 U.S.; +1 312 471-1353 international), passcode 5642050, or a live audio webcast and replay at pipersandler.com/earnings. Dial in at least 15 minutes early; replay and investor relations email are provided for access questions.
Piper Sandler (NYSE: PIPR) appointed Aamer Naseer as global head of life sciences outsourcing and B2B med tech, effective immediately as announced February 25, 2026.
Naseer brings 25 years of sector experience advising public and private medical device, manufacturing and outsourcing clients, positioned to expand the firm’s capabilities in life sciences outsourcing and B2B med tech.
Piper Sandler (NYSE: PIPR) hired Jason Arnold as a managing director in its healthcare investment banking group, based initially in London while serving global clients. Arnold will advise life science tools and diagnostics companies on M&A, strategic partnerships and capital raising, bringing 16 years of sector experience.
Previously a partner and managing director at William Blair, Arnold began his career at Ernst & Young and holds a bachelor’s and master’s from the University of Colorado, Boulder.
Piper Sandler (NYSE: PIPR) reported fourth quarter and full year 2025 results and announced a $5.00 per share special dividend, a $0.70 per share quarterly dividend, and a 4-for-1 stock split. The company will host an earnings conference call on Feb 6, 2026 at 7:00 a.m. CT with webcast and playback available on its investor website. Dial-in numbers and passcode were provided for live participation.
Piper Sandler (NYSE: PIPR) appointed Stuart M. Essig, Ph.D., to its board of directors effective February 4, 2026. Essig brings extensive healthcare and medical-technology experience, including prior roles as CEO, chairman and executive chairman of Integra LifeSciences and senior M&A experience at Goldman Sachs.
During his tenure at Integra, revenues grew from about $15 million to more than $1.6 billion. Essig also serves on the board of IDEXX Laboratories and previously served on boards including St. Jude Medical, Zimmer Biomet, Owens & Minor, and Orthofix.
Piper Sandler (NYSE: PIPR) announced the hire of Tim Carlson as managing director on its energy & power investment banking team, with a focus on upstream.
Carlson brings over 28 years of investment banking experience and has advised on more than 165 transactions totaling over $125 billion. He joins from Intrepid Partners and previously held senior roles at Evercore, JPMorgan and Bank of America Merrill Lynch.
Piper Sandler (NYSE: PIPR) completed the acquisition of MENA Growth Partners, a Abu Dhabi-based merchant bank that will serve as Piper Sandler's strategic investment banking hub in the GCC region.
Nabeel Siddiqui, currently a managing director in Piper Sandler's London office, will relocate to Abu Dhabi to lead the firm's regional investment banking while retaining responsibilities for his European business. The acquisition is intended to link Piper Sandler's expertise in energy, infrastructure, chemicals, healthcare, technology, equity capital markets and private capital advisory with MENA Growth Partners' regional relationships. Legal advisers on the deal included Al Tamimi & Company for Piper Sandler and Charles Russell Speechlys and TMF Group for MENA Growth Partners.